We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FC icon
1651
Franklin Covey
FC
$227M
$37.5K ﹤0.01%
826
DICE
1652
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$37.5K ﹤0.01%
1,848
GRC icon
1653
Gorman-Rupp
GRC
$2.11B
$37.4K ﹤0.01%
1,571
INBX
1654
DELISTED
Inhibrx, Inc. Common Stock
INBX
$37.4K ﹤0.01%
2,082
BBSI icon
1655
Barrett Business Services
BBSI
$800M
$37.1K ﹤0.01%
1,904
AORT icon
1656
Artivion
AORT
$1.39B
$37.1K ﹤0.01%
2,679
THRY icon
1657
Thryv Holdings
THRY
$96.9M
$37.1K ﹤0.01%
1,624
USNA icon
1658
Usana Health Sciences
USNA
$252M
$37K ﹤0.01%
660
WSR
1659
DELISTED
Whitestone REIT
WSR
$37K ﹤0.01%
4,372
-604
-12% -$6.2K
CIO
1660
DELISTED
City Office REIT
CIO
$36.9K ﹤0.01%
3,701
-637
-15% -$7.86K
NAPA
1661
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$36.9K ﹤0.01%
2,554
CVGW
1662
DELISTED
Calavo Growers
CVGW
$36.8K ﹤0.01%
1,159
CSTL icon
1663
Castle Biosciences
CSTL
$933M
$36.8K ﹤0.01%
1,410
GOGO icon
1664
Gogo Inc
GOGO
$377M
$36.8K ﹤0.01%
3,034
RGP icon
1665
Resources Connection
RGP
$145M
$36.7K ﹤0.01%
2,033
PNT
1666
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$36.7K ﹤0.01%
4,751
SHCR
1667
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$36.7K ﹤0.01%
+19,314
New +$33.8K
OSG
1668
Octave Specialty Group
OSG
$212M
$36.6K ﹤0.01%
2,874
RDFN
1669
DELISTED
Redfin
RDFN
$36.6K ﹤0.01%
6,273
LUNG icon
1670
Pulmonx
LUNG
$92.8M
$36.6K ﹤0.01%
2,196
MSBI icon
1671
Midland States Bancorp
MSBI
$698M
$36.6K ﹤0.01%
1,552
CHS
1672
DELISTED
Chicos FAS, Inc.
CHS
$36.6K ﹤0.01%
7,558
+1,885
+33% +$10.5K
SPNS
1673
DELISTED
Sapiens International
SPNS
$36.6K ﹤0.01%
1,907
MRC
1674
DELISTED
MRC Global
MRC
$36.6K ﹤0.01%
5,085
DAWN
1675
DELISTED
Day One Biopharmaceuticals
DAWN
$36.6K ﹤0.01%
1,825

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.